ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Delhi HC bars Natco Pharma from selling cancer drug Olaparib
The Delhi High Court has prohibited Natco Pharma from producing and selling the cancer drug Olaparib, marketed as 'BRACANAT' or under any other name, until further notice. The court's decision came in response to a lawsuit by Kudos Pharmaceuticals, which c
Announcement as on 04 March 2024

Natco Pharma Q3 results: Net profit rises over 3-fold to Rs 212.7 crore
Natco Pharma Ltd on Wednesday reported over three-fold rise in consolidated net profit at Rs 212.7 crore in the third quarter ended December 31, 2023 on the back of robust revenue growth. The company had posted a consolidated net profit of Rs 62.3 crore in
Announcement as on 14 February 2024

Natco Pharma Q3 net profit rises over 3-fold to Rs 212.7 crore
The company had posted a consolidated net profit of Rs 62.3 crore in the same period last fiscal, Natco Pharma said in a regulatory filing.
Announcement as on 14 February 2024

Natco Pharma Q3 net profit rises over 3-fold to Rs 212.7 crore
The company had posted a consolidated net profit of Rs 62.3 crore in the same period last fiscal, Natco Pharma said in a regulatory filing.
Announcement as on 14 February 2024

Natco Pharma trades 2% lower even as its Q2 net profit zooms 550% YoY
The Natco Pharma stock has given a return of 26.22 percent over the last six months. The benchmark Nifty50 index has given a return of 5.68 percent over the same duration.
Announcement as on 15 November 2023

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 973.92
  • 12Day Average: 936.68
  • 20Day Average: 899.02
  • 50Day Average: 881.28
  • 100Day Average: 869.99
  • 150Day Average: 870.84
  • 200Day Average: 883.76

524816 Indicators & signals

Indicator MACD (12,26,9)

940.92, 907.87, 21.99
Indicator MACD is in positive zone

Indicator ADX (14)

5.37, 30.44, 27.33
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Thu Mar 2026 1000.70 953.75 to 1003.70 5.03% 0.53 times
04 Wed Mar 2026 952.80 945.00 to 992.00 -0.38% 1.25 times
02 Mon Mar 2026 956.40 820.35 to 967.25 -3.23% 0.25 times
27 Fri Feb 2026 988.30 958.70 to 998.40 1.74% 0.53 times
26 Thu Feb 2026 971.40 963.95 to 994.70 -0.73% 0.44 times
25 Wed Feb 2026 978.55 942.85 to 990.45 3.61% 1.35 times
24 Tue Feb 2026 944.45 886.50 to 949.00 5.74% 4.64 times
23 Mon Feb 2026 893.20 887.00 to 906.10 0.27% 0.12 times
20 Fri Feb 2026 890.80 878.05 to 894.65 0.24% 0.28 times
19 Thu Feb 2026 888.70 881.00 to 931.15 -0.19% 0.72 times
18 Wed Feb 2026 890.40 863.20 to 898.35 0.67% 0.42 times
17 Tue Feb 2026 884.50 876.65 to 893.10 0.22% 0.75 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top